BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

610 related articles for article (PubMed ID: 17181487)

  • 1. Percutaneous radiofrequency ablation: minimally invasive therapy for renal tumors.
    Ahrar K; Wallace MJ; Matin SF
    Expert Rev Anticancer Ther; 2006 Dec; 6(12):1735-44. PubMed ID: 17181487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiofrequency ablation of small renal tumors.
    Johnson DB; Cadeddu JA
    Expert Rev Anticancer Ther; 2004 Feb; 4(1):77-83. PubMed ID: 14748659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ablative techniques for the management of kidney cancer.
    Hafron J; Kaouk JH
    Nat Clin Pract Urol; 2007 May; 4(5):261-9. PubMed ID: 17483811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A critical analysis of the actual role of minimally invasive surgery and active surveillance for kidney cancer.
    Heuer R; Gill IS; Guazzoni G; Kirkali Z; Marberger M; Richie JP; de la Rosette JJ
    Eur Urol; 2010 Feb; 57(2):223-32. PubMed ID: 19853989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple nephron-sparing procedures in solitary kidney with recurrent, metachronous, nonfamilial renal cell carcinoma.
    Nosnik IP; Mouraviev V; Nelson R; Polascik TJ
    Urology; 2006 Dec; 68(6):1343.e1-3. PubMed ID: 17141824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimally invasive nephron-sparing surgery.
    Berger A; Crouzet S; Canes D; Haber GP; Gill IS
    Curr Opin Urol; 2008 Sep; 18(5):462-6. PubMed ID: 18670268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous radiofrequency ablation with transarterial embolization is useful for treatment of stage 1 renal cell carcinoma with surgical risk: results at 2-year mean follow up.
    Arima K; Yamakado K; Kinbara H; Nakatsuka A; Takeda K; Sugimura Y
    Int J Urol; 2007 Jul; 14(7):585-90; discussion 590. PubMed ID: 17645597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term oncological and overall outcomes of percutaneous radio frequency ablation in high risk surgical patients with a solitary small renal mass.
    Levinson AW; Su LM; Agarwal D; Sroka M; Jarrett TW; Kavoussi LR; Solomon SB
    J Urol; 2008 Aug; 180(2):499-504; discussion 504. PubMed ID: 18550123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiofrequency ablation in combination with embolization in metachronous recurrent renal cancer in solitary kidney after contralateral tumor nephrectomy.
    Gebauer B; Werk M; Lopez-Hänninen E; Felix R; Althaus P
    Cardiovasc Intervent Radiol; 2007; 30(4):644-9. PubMed ID: 17436034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiofrequency ablation of renal tumors in the solitary kidney.
    Krambeck AE; Farrell MA; Callstrom MR; Atwell TD; Charboneau JW; Chow GK; Dimarco DS; Patterson DE
    Can J Urol; 2008 Aug; 15(4):4163-8; discussion 4168. PubMed ID: 18706143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiofrequency ablation for T1a tumors in a solitary kidney: promising intermediate oncologic and renal function outcomes.
    Raman JD; Thomas J; Lucas SM; Bensalah K; Lotan Y; Trimmer C; Cadeddu JA
    Can J Urol; 2008 Apr; 15(2):3980-5. PubMed ID: 18405445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimally invasive nephron sparing management for renal tumors in solitary kidneys.
    Turna B; Kaouk JH; Frota R; Stein RJ; Kamoi K; Gill IS; Novick AC
    J Urol; 2009 Nov; 182(5):2150-7. PubMed ID: 19758655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermediate comparison of partial nephrectomy and radiofrequency ablation for clinical T1a renal tumours.
    Stern JM; Svatek R; Park S; Hermann M; Lotan Y; Sagalowsky AI; Cadeddu JA
    BJU Int; 2007 Aug; 100(2):287-90. PubMed ID: 17617136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimally invasive surgery using ablative modalities for the localized renal mass.
    Kimura M; Baba S; Polascik TJ
    Int J Urol; 2010 Mar; 17(3):215-27. PubMed ID: 20070411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous radio frequency ablation of renal tumors in patients with von Hippel-Lindau disease: preliminary results.
    Park BK; Kim CK
    J Urol; 2010 May; 183(5):1703-7. PubMed ID: 20299060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephron-sparing surgery for renal cell carcinoma in the solitary kidney.
    Berdjis N; Hakenberg OW; Novotny V; Manseck A; Oehlschläger S; Wirth MP
    Scand J Urol Nephrol; 2007; 41(1):10-3. PubMed ID: 17366096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Choice of operation for clinically localized renal tumor.
    Nguyen CT; Campbell SC; Novick AC
    Urol Clin North Am; 2008 Nov; 35(4):645-55; vii. PubMed ID: 18992618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermediate oncological outcomes of percutaneous radiofrequency ablation for small renal tumors: initial experience.
    Nitta Y; Tanaka T; Morimoto K; Makino T; Nishikawa N; Tashiro K; Naganuma T; Iguchi T; Matsuoka T; Nakatani T
    Anticancer Res; 2012 Feb; 32(2):615-8. PubMed ID: 22287753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous radiofrequency ablation of renal cell carcinomas in patients with von Hippel Lindau disease previously undergoing a radical nephrectomy or repeated nephron-sparing surgery.
    Park SY; Park BK; Kim CK; Lee HM; Jeon SS; Seo SI; Jeong BC; Choi HY
    Acta Radiol; 2011 Jul; 52(6):680-5. PubMed ID: 21525107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laparoscopic partial nephrectomy in the treatment of renal cell carcinoma: a minimally invasive means to nephron preservation.
    Blitstein J; Ghavamian R
    Expert Rev Anticancer Ther; 2008 Jun; 8(6):921-7. PubMed ID: 18533801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.